Improvement of walking ability in patients with adrenoleukodystrophy treated with fampridine as compassionate use
Neurologia (Engl Ed)
.
2021 Jun;36(5):393-395.
doi: 10.1016/j.nrleng.2020.07.018.
Epub 2021 Mar 26.
Authors
M I Morales-Casado
1
,
N López-Ariztegui
2
,
F Muñoz-Escudero
2
,
Á Navarro-Bejarano
3
,
J A Pérez-Matos
2
Affiliations
1
Servicio de Neurología, Hospital Virgen de la Salud, Toledo, Spain. Electronic address: mimorales@sescam.jccm.es.
2
Servicio de Neurología, Hospital Virgen de la Salud, Toledo, Spain.
3
Terapia ocupacional, Hospital Casaverde Madrid, Navalcarnero, Madrid, Spain.
PMID:
34714240
DOI:
10.1016/j.nrleng.2020.07.018
No abstract available
Publication types
Letter
MeSH terms
4-Aminopyridine
Adrenoleukodystrophy* / drug therapy
Compassionate Use Trials*
Humans
Potassium Channel Blockers / therapeutic use
Walking
Substances
Potassium Channel Blockers
4-Aminopyridine